A METHOD FOR IDENTIFYING CONSTITUTIVELY ACTIVE MUTANTS OF MITOGEN ACTIVATED PROTEIN KINASES (MAPK) AND USES THEREOF

David Engelberg (Inventor), Michal Bell (Inventor), Alexander Levitzki (Inventor)

Research output: Patent

Abstract

The present invention relates to a method of screening for constitutively active mutants of a desired eukaryotic MAPK pathway member of a MAPK pathway member, comprising the steps of (a) providing a mutant yeast strain devoid of an upstream kinase; (b) providing a DNA library of different mutants of a mutagenized gene coding for the desired MAPK pathway member; (c) introducing said library into said yeast strain under conditions suitable for activation of the yeast MAPK pathway; (d) detecting an end-point indication for activation of the yeast pathway; and (e) optionally isolating said constitutively activated mutant from selected rescued clones. The invention further relates to isolated constitutively active mutants of the MAPK pathway member, and their various uses particularly, in a method of screening for substances which are inhibitors of a MAPK pathway, and in drug design.

Original languageAmerican English
Patent numberWO02081746
IPCC12N 15/ 10 A I
Priority date5/04/01
StatePublished - 17 Oct 2002

Fingerprint

Dive into the research topics of 'A METHOD FOR IDENTIFYING CONSTITUTIVELY ACTIVE MUTANTS OF MITOGEN ACTIVATED PROTEIN KINASES (MAPK) AND USES THEREOF'. Together they form a unique fingerprint.

Cite this